Malignant and benign pheochromocytoma: chromaffin granule transmitters and the response to medical and surgical treatment

Ann N Y Acad Sci. 2002 Oct:971:530-2. doi: 10.1111/j.1749-6632.2002.tb04519.x.

Authors

Fangwen Rao¹, Harry R Keiser, Daniel T O'Connor

Affiliation

¹ Department of Medicine and Center for Molecular Genetics, University of California, San Diego, San Diego, California 92161, USA.

PMID: 12438175
DOI: 10.1111/j.1749-6632.2002.tb04519.x

No abstract available

Publication types

Clinical Trial
Research Support, Non-U.S. Gov't
Research Support, U.S. Gov't, Non-P.H.S.
Research Support, U.S. Gov't, P.H.S.

MeSH terms

Adrenal Gland Neoplasms / blood
Adrenal Gland Neoplasms / diagnosis
Adrenal Gland Neoplasms / drug therapy*
Antineoplastic Combined Chemotherapy Protocols / therapeutic use
Chromogranin A
Chromogranins / blood
Chromogranins / metabolism
Cyclophosphamide / administration & dosage
Dacarbazine / administration & dosage
Epinephrine / metabolism
Humans
Norepinephrine / metabolism
Pheochromocytoma / blood
Pheochromocytoma / diagnosis*
Pheochromocytoma / drug therapy*
Vincristine / administration & dosage

Substances

Chromogranin A
Chromogranins
Vincristine
Dacarbazine
Cyclophosphamide
Norepinephrine
Epinephrine